Biosimilars
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Know the Challenges of Biosimilar Manufacturing
Best practices for a competitive marketJerry Martin and Michiel Ultee 09.06.17
-
Bio News | Breaking News | Facilities | Industry News
Lonza Pharma & Biotech Launches Ibex Solutions
Represents an innovative new concept in biological manufacturing and development07.31.17
-
The Analytical Challenges of the Biosimilar Boom
The growing biosimilar industry and its implications on the current drug marketMario DiPaola, Senior Scientific Director, Charles River Laboratories 07.03.17
-
Bio News | Breaking News | cGMP Manufacture | Facilities | Industry News
Axis Biotec, PlantForm Enter Bio Mfg. Pact
Plans call for construction of an innovative tobacco-based biopharma expression and pilot manufacturing facility in Brazil06.26.17
-
Differentiating in the Biosimilar Market: Surviving the Cost of Entry
Companies need to improve customer experience, produce additional evidence, and create valuable engagement with stakeholdersMichael Turner and Magnus Franzen, Life Sciences Experts, PA Consulting Group 06.19.17
-
Bio News
Know the Challenges of Biosimilar Manufacturing
Best Practices for a Competitive MarketJerry Martin, Pharmaceutical and Life Sciences Consultant to PMMI, and, Dr. Michiel Ultee, Principal, Ulteemit BioConsulting, LLC 06.12.17
-
cGMP Manufacture
Biopharmaceutical Contract Manufacturing Market
The market continues to grow, projected to exceed $4 billion in 2017William Downey, President, HighTech Business Decisions 06.06.17
-
Indian Generic Firms Expand Biosimilar Portfolios
With more players entering the ring, the race to enter the promising biosimilars market is getting hotter by the day in IndiaS. Harachand, Contributing Editor 05.09.17
-
Bio News | Breaking News | Facilities | Industry News
Sartorius Stedim Biotech Launches Chemistry Testing Services
To be offered by subsidiary BioOutsource05.05.17
-
Samsung Bioepis Obtains First Drug Approval in the U.S.
FDA approves biosimilar Renflexis across all eligible indications04.24.17
-
Regulatory Affairs
FDA’s Final Guidance: Steering Studies to Support Biosimilar Approval
IP attorney, Stacie Ropka, shares insight on this latest guidance and how it might impact the biosimilar marketOnline Exclusives Kristin Brooks, Contract Pharma 04.20.17
-
CMOs & Biosimilars Mfg. in the U.S.
Biosimilars are moving from novel opportunity to mainstream productEric S. Langer and Ronald A. Rader, BioPlan Associates 04.20.17
-
Bio News | Breaking News | Industry News
China FDA Accepts JHL's First Clinical Trial Application
JHL1101 is a biosimilar that JHL is pursuing as part of its strategic biologics alliance with Sanofi04.10.17
-
Biosimilars Update
Fulfilling a dire need, but at what (human) cost?Ben Locwin, Contributing Editor 04.03.17
-
Bio News | Breaking News | cGMP Manufacture | Facilities | Industry News
Biocon Wins $68M Contract for Biosimilar Insulin
Will supply rh-insulin manufactured at its new facility in Malaysia01.26.17
-
Qualification of an Assay
With applications for investigating functional comparability of an originator and biosimilarNicolas Fourrier, Director Biomarker and Biopharmaceutical Testing, SGS; Abhishek Saharia, Director of Cell-Based Assays & Biologics, DiscoverX; Fiona Greer, Global Director, Biopharma Services Development, Life Sciences, SGS 11.30.16
-
Bio News | Breaking News | Industry News
Mabion Forms Pact With Mylan
Signs supply and commercialization agreement with Mylan regarding Mabion CD20 for EU11.11.16
-
Bio News | Breaking News | Industry News
Eagle Pharmaceuticals Acquires Arsia Therapeutics for up to $78M
Marks entry into biosimilar market11.11.16
-
Fill/Finish | Industry News
Samsung Bioepis, Catalent in Biosimilar Supply Pact
Catalent to provide fill-finish production services for biosimilar to Enbrel10.18.16
-
Bio News | Breaking News | Facilities | Industry News
GE to Invest €150mn in Biopharma Manufacturing
Plans to establish four prefabricated, off-the-shelf biologics factories for GE customers in GE BioPark Cork09.19.16
